Abstract Ref Number = APCP40
Invited Speakers
Drug Access and Availability
JeanPierre Chanoine Clinical Professor, Division of Endocrinology,Department of Pediatrics University of British Columbia, Canada
The World Health Organisation (WHO) maintains a list of essential medicines for children (EMLc) that is revised every two years. This list serves as a non-binding template for national lists of medicines prepared by the health authorities in most countries in the world. Endocrine conditions are diseases of the hormonal system that are part of the non-communicable diseases. They include: diabetes, abnormal growth and puberty, hypo- or hyperthyroidism, adrenal insufficiency, disorders of sexual development, hypocalcemia or bone abnormalities. In resource-rich countries these conditions are well managed thanks to the availability of appropriate and affordable medicines. However, in resource-poor countries, many affordable, life-saving medicines are not registered, causing morbidity and mortality that could easily be prevented! If registered, they may not always be available to the patient. We will discuss the barriers and opportunities associated with access to essential medicines in pediatric endocrinology and diabetes.
Disclaimer: The Views and opinions expressed in the articles are of the authors and not of the journal.
Journal Office
Mid City Hospital, 3-A Shadman II
Jail Road, Lahore ,Pakistan
Associate Editor
Dr. Muhammad Faheem Afzal
Support & Help
e-Journal Administrator
Dr. Khalid Masud